19 März 2026

Digital Shift in Pharmaceutical Testing

Digital transformation is reshaping pharmaceutical R&D & QC, raising expectations for automation, data integrity, and real‑time insights. SOTAX provides instruments & compliant data solutions that modernize workflows & support evolving regulatory demands.

Pharmaceutical manufacturers worldwide are moving toward a data‑driven, continuously assured quality model – guided by initiatives such as ICH Q13, Annex 11 modernization, and emerging AI governance frameworks. This evolution places new emphasis on measurement integrity, automated workflows, and traceable analytics across both laboratory and at‑line environments.

SOTAX contributes a focused, interoperable quality layer that supports this transition: automated dissolution, standardized content‑uniformity and assay preparation, at‑line physical testing, and governed digital data management. These capabilities help organizations enhance process understanding, reduce variability, and move closer to real‑time release principles.

To explore how global regulatory trends and modern laboratory technologies converge, we have compiled a technical white paper covering scientific, regulatory, and practical implementation considerations.